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Chromosomal insertions defining Bordetella bronchiseptica siderophore phenotypic complementation group
III mutants BRM3 and BRM5 were found to reside approximately 200 to 300 bp apart by restriction mapping
of cloned genomic regions associated with the insertion markers. DNA hybridization analysis using B. bronchi-
septica genomic DNA sequences flanking the cloned BRM3 insertion marker identified homologous Bordetella
pertussis UT25 cosmids that complemented the siderophore biosynthesis defect of the group III B. bronchiseptica
mutants. Subcloning and complementation analysis localized the complementing activity to a 2.8-kb B. pertussis
genomic DNA region. Nucleotide sequencing identified an open reading frame predicted to encode a polypep-
tide exhibiting strong similarity at the primary amino acid level with several pyridoxal phosphate-dependent
amino acid decarboxylases. Alcaligin production was fully restored to group III mutants by supplementation
of iron-depleted culture media with putrescine (1,4-diaminobutane), consistent with defects in an ornithine
decarboxylase activity required for alcaligin siderophore biosynthesis. Concordantly, the alcaligin biosynthesis
defect of BRM3 was functionally complemented by the heterologous Escherichia coli speC gene encoding an
ornithine decarboxylase activity. Enzyme assays confirmed that group III B. bronchiseptica siderophore-defi-
cient mutants lack an ornithine decarboxylase activity required for the biosynthesis of alcaligin. Siderophore
production by an analogous mutant of B. pertussis constructed by allelic exchange was undetectable. We
propose the designation odc for the gene defined by these mutations that abrogate alcaligin siderophore
production. Putrescine is an essential precursor of alcaligin in Bordetella spp.
Nutritional iron limitation, mediated primarily by specific
host iron-binding glycoproteins, is a front-line host defense
against disease-causing infectious agents. Strategies aimed at
defeating host iron restriction may involve the action of low-
molecular-mass, high-affinity, ferric iron-specific chelators of
microbial origin, termed siderophores, that are synthesized
coordinately with their cognate surface receptors and transport
machinery in response to iron starvation (28). The role of
siderophores in microbial pathogenesis is well established (29,
53, 54).
Bordetella pertussis, the causative agent of human whooping
cough or pertussis, and Bordetella bronchiseptica, the agent of
swine atrophic rhinitis and kennel cough in dogs, are mucosal
pathogens that colonize the upper respiratory tracts of their
mammalian hosts. In the first reported molecular genetic stud-
ies of Bordetella iron acquisition systems, Armstrong and
Clements (3) described the isolation of B. bronchiseptica mu-
tants deficient in siderophore activity following transposon mu-
tagenesis. DNA hybridization analysis using DNA probe se-
quences flanking the transposon insertions established the
existence of homologs of B. bronchiseptica siderophore genes
in B. pertussis. Reciprocal cross-feeding experiments provided
additional support for the hypothesis that the hydroxamate
siderophores produced and utilized by B. pertussis and B. bron-
chiseptica were structurally similar or identical. In a subsequent
report, complementation of deregulated iron transport system
mutants of B. bronchiseptica by the fur gene of B. pertussis (9)
confirmed the involvement of common regulatory determi-
nants governing iron transport in the two related species.
Recent purification and spectroscopic analysis of Bordetella
siderophores (10, 33) found that the iron chelators produced
by both B. pertussis and B. bronchiseptica were identical to the
potent macrocyclic dihydroxamate siderophore alcaligin, 1,8(S),
11,18(S)-tetrahydroxy-1,6,11,16-tetraazacycloeicosane-2,5,12,
15-tetrone (molecular formula, C16H28N4O8; molecular weight,
404), previously isolated from the taxonomically related bac-
terial species Alcaligenes denitrificans subsp. xylosoxydans (35,
36). Evidence for biological activity of the purified sid-
erophores was gathered with growth stimulation and 55Fe-
alcaligin transport assays of Bordetella spp. (10). Uptake rates
and saturability of iron uptake observed in 55Fe transport as-
says were indicative of a high-affinity ferric alcaligin transport
system and provided the first direct evidence, beyond simple
growth stimulation assays, of alcaligin-mediated Bordetella iron
transport.
We report the identification of a gene encoding an alcaligin
siderophore biosynthetic activity defined by previously re-
ported transposon mutations abrogating alcaligin production
in B. bronchiseptica (3) as an ornithine decarboxylase (Odc)
gene, indicating that putrescine is an essential precursor for
alcaligin siderophore biosynthesis in Bordetella spp.
MATERIALS AND METHODS
Bacterial strains and plasmids. B. bronchiseptica B013N, a nalidixic acid-
resistant derivative of strain B013, and the isolation of siderophore biosynthetic
mutants BRM3 and BRM5 by mini-Tn5/lacZ1 (16) insertional inactivation have
been described previously (3). Virulent-phase B. pertussis UT25 has also been
described previously (18). Escherichia coli DH5a [F2 F80dlacZDM15 D(lacZYA-
argF)U169 endA1 recA1 hsdR17(rK2 mK1) deoR thi-1 supE44 l2 gyrA96 relA1]
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(Bethesda Research Laboratories, Gaithersburg, Md.) was used as the host strain
for routine plasmid construction and propagation and as the donor strain in
conjugal transfer of plasmids to Bordetella strains. Plasmid pRK/3.2P, carrying
the speC constitutive ornithine decarboxylase gene of E. coli, was constructed by
subcloning the 3.2-kb E. coli PstI insert DNA fragment of plasmid pODC1 (8)
into the broad-host-range plasmid vector pRK415 (26). DH5a (pRK2013) was
used as the source of plasmid-encoded mobilization functions (19) in triparental
matings to transfer the cosmid pCP13-based gene bank of B. pertussis UT25 (11)
as well as plasmid vector pRK415 derivatives to Bordetella strains. E. coli K38
(pGP1-2) (46) was used as the host strain in Bordetella protein expression studies.
Growth conditions. B. pertussis was maintained on Bordet-Gengou agar plates
(7), and B. bronchiseptica was maintained on blood agar plates or standard
Luria-Bertani agar plates. Modified Stainer-Scholte medium (39, 41) (SS) was
used for broth cultures of Bordetella spp. Iron-replete and iron-depleted SS
culture conditions were achieved by the methods of Armstrong and Clements
(3); media and supplements were deferrated with Chelex-100 resin (Bio-Rad
Laboratories, Richmond, Calif.). Tetracycline was used at 15 mg/ml to select for
pCP13-based cosmids and pRK415 plasmid derivatives. Kanamycin was used at
50 mg/ml for maintenance of pRK2013 and pGP1-2 and for selection of kana-
mycin cassette insertion markers in allelic exchange procedures, while ampicillin
was used at 100 mg/ml for maintenance of other plasmids in E. coli. Culture
media were supplemented as required with cadaverine, agmatine, putrescine,
ornithine, arginine, or spermidine at a 50-mg/ml final concentration, or with
1,4-diamino-2-butanone dihydrochloride (DAB) (Sigma Chemical Co., St. Louis,
Mo.) at concentrations ranging from 0 to 2 mM. All glassware was acid cleaned
and rinsed repeatedly in distilled deionized water prior to use. Optical densities
of SS cultures were monitored with a Klett-Summerson colorimeter fitted with a
no. 54 filter (Klett Manufacturing Co., Long Island City, N.Y.).
Conjugation. Conjugal transfer of pCP13 and pRK415 derivatives to Bordetella
strains was accomplished by triparental matings with E. coliDH5a as the plasmid
donor strain and DH5a (pRK2013) as the source of mobilization functions.
Suspensions of donor, helper, and recipient strains in SS plus 10 mM MgSO4
were combined at an estimated 1:1:3 cell ratio, spotted onto Luria-Bertani or
blood agar plates (for B. bronchiseptica recipients) or Bordet-Gengou agar plates
(for B. pertussis recipients), and incubated at 378C for 3 to 5 h. Bacteria were
streaked from mating spots directly onto agar plates containing the appropriate
selective antibiotics and crude colicin B (3, 12). Plates were incubated at 378C for
1 to 4 days, at which time transconjugant colonies were apparent.
Routine DNA procedures. DNA cloning and hybridization analysis were per-
formed as described previously (38), and transformation of E. coli was by the
CaCl2 method of Cohen and coworkers (14).
Radiochemicals. Tran 35S-label used for radiolabeling plasmid-encoded B.
pertussis proteins in E. coli, [32P]dATP for nucleotide sequencing, and [32P]dCTP
for DNA hybridization analysis were purchased from ICN Radiochemicals (Ir-
vine, Calif.). L-[1-14C]ornithine used in Odc assays was obtained from NEN
Research Products (Wilmington, Del.).
Conditional expression of plasmid-encoded Bordetella proteins in E. coli. Ex-
clusive expression of Bordetella proteins in E. coli used the temperature-sensitive
T7 RNA polymerase-promoter system of Tabor and Richardson (46). Recom-
binant plasmid pT7/odc carries an approximately 2.8-kb odc1 DNA fragment of
B. pertussis UT25 in the T7 promoter plasmid vector pGEM4Z (Promega Cor-
poration, Madison, Wis.). Sodium dodecyl sulfate (SDS)-polyacrylamide gel
electrophoresis of radiolabeled bacterial cell proteins was performed essentially
as described previously (27).
Nucleotide sequencing. Nucleotide sequencing was performed by the dideoxy
chain termination method with a Sequenase version 2.0 kit (United States Bio-
chemical Corp., Cleveland, Ohio). Double-stranded plasmid templates were
isolated by the alkaline lysis procedure (6) and further purified by precipitation
in the presence of 500 mM sodium chloride and 6.5% polyethylene glycol 8000.
Nucleotide sequence data were derived from plasmid subclones of odc1 B.
pertussis cosmids, as well as from a collection of deletion derivatives generated by
treatment of odc1 plasmid subclones with exonuclease III (21) by using a com-
mercially available kit (Erase-a-Base; Promega Corporation) or from deletion
derivatives resulting from in vivo intramolecular transposition of transposon gd
(52) with the Deletion Factory System version 2.0 (Life Technologies, Inc.,
Gaithersburg, Md.). Nucleotide sequence data management and analysis used
DNA Strider 1.2 software (Service de Biochimie et de Ge´ne´tique Mole´culaire,
Gif sur Yvette, France) for the Macintosh computer. Database searches and data
retrievals used the BLAST (1) and RETRIEVE electronic mail servers devel-
oped by the National Center for Biotechnology Information at the National
Library of Medicine. For protein database BLASTP searches, Bordetella DNA
sequences were translated in all six possible reading frames, and the resulting
amino acid sequences were transmitted to the National Center for Biotechnology
Information for analysis. Multiple amino acid sequence alignments were per-
formed with the MegAlign module of a demonstration version of the Lasergene
sequence analysis software system for the Power Macintosh computer (DNA
STAR, Inc., Madison, Wis.).
Siderophore assays. Chrome azurol S (CAS) agar plates for scoring of B.
bronchiseptica siderophore production were prepared as described by Armstrong
and Clements (3). The CAS universal siderophore detection assay (40) was used
to monitor siderophore production by Bordetella strains grown in liquid culture
by measuring the decrease in A630 of the CAS dye reaction mixture as reported
previously (3). Siderophore activities are expressed relative to uninoculated
complete culture medium. Siderophore assays were performed in triplicate in
multiple experimental trials. Purified alcaligin used in control siderophore activ-
ity assays and spectroscopic analysis was isolated from B. bronchiseptica cultures
by the simplified large-scale method described by Brickman and coworkers (10).
Determination of hydroxamates was by the method of Csaky (15) with hydrox-
ylamine hydrochloride as standard. Visible and UV spectroscopy used a Beck-
man DU-65 spectrophotometer (Beckman Instruments, Inc., Fullerton, Calif.).
Inhibition of alcaligin siderophore production by a competitive inhibitor of
Odc activity. Wild-type B. bronchiseptica B013N was cultured overnight in iron-
replete SS, and then bacterial cells from 200 ml of culture were harvested by
centrifugation, washed twice with 1-ml volumes of iron-depleted SS, and used to
seed 20 ml of iron-depleted SS. The resulting suspension was divided among
sterile culture tubes, and a 0.5 M stock solution of aqueous DAB, a competitive
inhibitor of Odc activity (13), was added to the first tube to provide 2 mM final
concentration. DAB was diluted serially 1:5 through the series of culture tubes,
yielding starting cultures containing DAB at 2.000, 0.400, 0.080, 0.016, 0.003, and
0.001 mM final concentrations. A control culture had no DAB added. Cultures
were incubated with shaking at 378C for 18 h and then assayed for siderophore
production by the CAS method.
Odc enzyme assays. Odc activities of Bordetella strains were assayed by a
modification of the method described by Tabor and coworkers (44, 45) for mass
screening of polyamine biosynthetic mutants. Odc activities were determined for
Bordetella strains grown under iron-replete or iron-depleted SS culture condi-
tions to examine whether expression of Odc activity was iron regulated. Borde-
tella strains grown for approximately 20 h in iron-replete SS were subcultured
1:200 into iron-replete or iron-depleted SS and grown with shaking at 378C for an
additional 16 to 18 h, corresponding to mid- to late logarithmic growth phase. A
volume of each culture equivalent to 2 optical density units (600-nm wavelength)
of bacterial cells (usually 0.5 to 1 ml) was pelleted gently in a microcentrifuge,
washed twice with 1-ml volumes of a cold buffer consisting of 20 mM Tris-HCl
(pH 8.0)–5 mM dithiothreitol–1 mM EDTA (TDE buffer), and resuspended in
100 ml of cold TDE. Twofold serial dilutions of cell suspensions were prepared
in cold TDE buffer, and then to each dilution an equal volume of cold TDE–2%
toluene emulsion was added. Fifty-microliter volumes of the resulting cell sus-
pensions in TDE–1% toluene, equivalent to 2 3 108, 1 3 108, and 5 3 107
bacterial cells on the basis of absorbance measurements, were plated in triplicate
in 96-well trays and incubated at 378C for 30 min for permeabilization. Fifty
microliters of an Odc reaction mixture consisting of 20 mM Tris-HCl (pH 8.0)–5
mM dithiothreitol–50 mM pyridoxal phosphate–1 mg of bovine serum albumin
ml21–100 mM L-[1-14C]ornithine (0.3 mCi/ml) was added to each well, and then
the plates were covered with filter paper wetted with a freshly prepared saturated
solution of barium hydroxide to trap evolved 14CO2 as insoluble barium carbon-
ate. The 96-well tray lids were replaced, and the plates were wrapped in plastic
wrap, clamped securely to provide tight contact of the filter paper over the wells,
and incubated at 378C. After 2 to 3 h, the filter paper was removed, rinsed briefly
in acetone, air dried, and subjected to autoradiography for 2 to 5 days. Autora-
diographs were optically scanned, and digitized images were integrated with the
National Institutes of Health Image version 1.57 image processing and analysis
program for the Macintosh computer. The areas of the dried filters correspond-
ing to each well were excised, and captured [14C]barium carbonate was quanti-
fied with EcoLume scintillant (ICN Biomedicals, Inc.) in a Beckman LS5000TD
liquid scintillation counter (Beckman Instruments, Inc.). Nonenzymatic back-
ground levels of 14CO2 evolution in Odc assays were determined with B013N cell
suspensions that were boiled for 10 min prior to dilution with TDE–2% toluene.
Siderophore levels of the cultures used in these experiments were monitored by
CAS assay.
Construction of a B. pertussis odc mutant by allelic exchange. The 59-coding
region of the B. pertussis odc gene was deleted from a cloned 8.5-kb XhoI DNA
fragment by substitution of an internal 3.8-kb EcoRI B. pertussis DNA fragment
with a 2.1-kb Tn5-derived kanamycin resistance cassette in the allelic exchange
plasmid vector pRTP1 (42). The resulting deletion-replacement plasmid con-
struct was conjugally transferred to a spontaneous streptomycin-resistant deriv-
ative of B. pertussisUT25, UT25Sm1 (2), and the mutation was transferred to the
chromosome by homologous recombination as described by Stibitz and cowork-
ers (42). Reciprocal exchange was verified by Southern hybridization analysis.
The resulting Dodc::Kan B. pertussis mutant was designated P12.
Nucleotide sequence accession number. The GenBank accession number as-
signed to the partial B. pertussis UT25 odc nucleotide sequence is U34895.
RESULTS
Transposon insertions defining group III siderophore-defi-
cient mutants of B. bronchiseptica interrupt a genetic region
predicted to encode an amino acid decarboxylase. Molecular
cloning of mini-Tn5/lacZ1 transposon insertion markers asso-
ciated with group III B. bronchiseptica siderophore-deficient
mutants BRM3 and BRM5, resulting in recombinant plasmids
pBRM3 and pBRM5, was accomplished in a previous study
(3). B. bronchiseptica genomic sequences flanking the inser-
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tions were used in DNA hybridization analysis to demonstrate
the existence of homologous sequences in the related species
B. pertussis. Restriction mapping estimated that the chromo-
somal sites of the BRM3 and BRM5 insertions were separated
by approximately 200 to 300 bp. BRM3 and BRM5 displayed
no significant growth defect other than the inability to cope
with iron starvation.
To isolate the B. pertussis homolog of the mutated group III
siderophore gene(s), an approximately 700-bp NotI-SalI frag-
ment of pBRM3 was used to probe a B. pertussisUT25 cosmid-
based genomic library by in situ DNA hybridization. Four
distinct recombinant cosmids that hybridized strongly with the
B. bronchiseptica DNA probe at high stringency were identi-
fied. Restriction mapping and Southern hybridization analysis
of the four cosmids, pCP3.1, pCP3.2, pCP3.3, and pCP3.4,
determined that they shared B. pertussis DNA sequences ho-
mologous to the B. bronchiseptica DNA region interrupted by
the insertions defining the group III siderophore-deficient mu-
tants (data not shown). All four B. pertussis cosmids restored
wild-type levels of iron-regulated siderophore production to mu-
tants BRM3 and BRM5 when introduced by conjugal transfer,
as determined by the CAS siderophore assay and absorption
spectroscopy of iron-depleted culture supernatants. Subclon-
ing and complementation analysis established that the cosmids
shared an 8.5-kb XhoI B. pertussis UT25 genomic DNA frag-
ment that encoded the complementing activity (Fig. 1). Cos-
mid pCP3.3 was selected for further examination. Comple-
mentation analysis of pCP3.3 plasmid subclones and deletion
derivatives mapped the genetic region encoding the comple-
menting activity to an approximately 2.8-kb B. pertussis DNA
fragment extending from a B. pertussis NotI restriction site to a
terminus generated by exonuclease III treatment; the genetic
limits of this fragment are depicted in Fig. 1. The minimal
complementing plasmid pRK/143.1 carries the 2.8-kb fragment
in the broad-host-range plasmid vector pRK415.
Nucleotide sequencing analysis of pBRM3 and pBRM5 with
synthetic oligonucleotide primers complementary to the mini-
Tn5/lacZ1 transposon ‘‘I’’ and ‘‘O’’ ends confirmed that the
BRM3 and BRM5 chromosomal insertions were separated by
222 bp. Nucleotide sequences flanking the cloned transposon
insertions were identical to corresponding sequences deter-
mined later for the complementing B. pertussis DNA. Nucle-
otide sequencing of pCP3.3 plasmid subclones and deletion
derivatives and subsequent BLAST database searches of the
translated B. pertussis DNA sequences identified high-scoring
segment pairs with a family of pyridoxal phosphate-dependent
amino acid decarboxylase protein sequences. These decarboxy-
lases included LDC, the lysine decarboxylase of Hafnia alvei
(17); CadA, the inducible lysine decarboxylase of E. coli (32);
Adi, the biodegradative arginine decarboxylase of E. coli (43);
SpeC, the constitutive biosynthetic Odc of E. coli (4); and
SpeF, the inducible Odc of E. coli (25). The putative B. per-
tussis decarboxylase homolog was encoded by a DNA region
corresponding to the B. bronchiseptica genomic region dis-
rupted by the transposon insertions defining BRM3 and BRM5
(Fig. 1).
Over the highest-scoring 63-amino-acid segment of similar-
ity with the decarboxylases, multiple sequence alignments
found 54% identity of the deduced partial Bordetella amino
acid sequence with LDC, 52% identity with CadA, 46% with
Adi, and 38% with both SpeC and SpeF. A multiple amino acid
sequence alignment of this region is shown in Fig. 2. Percent
identity between the deduced B. pertussis polypeptide and each
of the same known decarboxylases over a 20-amino-acid region
spanning the highly conserved pyridoxal phosphate cofactor-
binding site ranged from 50 to 80.
Expression of a putative Bordetella amino acid decarboxyl-
ase protein in E. coli. The 2.8-kb B. pertussisDNA fragment in-
cluding the region encoding the putative pyridoxal phosphate-
dependent amino acid decarboxylase homolog was subcloned
into plasmid vector pGEM4Z to produce pT7/odc, allowing
bacteriophage T7 promoter-directed expression of Bordetella
proteins in E. coli K38 (pGP1-2). Plasmid pT7/odc-encoded
proteins were exclusively 35S radiolabeled and analyzed by
SDS-polyacrylamide gel electrophoresis and autoradiography.
A B. pertussis DNA-encoded product of approximately 86 kDa
in apparent molecular mass was consistently observed in auto-
radiographs of SDS-polyacrylamide gels (Fig. 3), as was the
T7-transcribed vector b-lactamase product(s) also seen in
pGEM4Z vector control samples. The observed 86-kDa mo-
lecular-mass product is within the calculated limits of the cod-
ing capacity of the 2.8-kb DNA fragment and approximates the
82- to 84-kDa mass of the homologous decarboxylases identi-
fied in database searches.
Restoration of alcaligin siderophore production to mutant
BRM3 by culture medium supplementation with amino acid
decarboxylase products. In an attempt to circumvent the sid-
erophore biosynthesis defect associated with the loss of a pu-
tative amino acid decarboxylase activity in group III mutant
BRM3, iron-depleted SS culture medium was supplemented
with cadaverine, agmatine, or putrescine, which are the prod-
FIG. 1. Restriction map of the B. pertussis UT25 genomic region comple-
menting alcaligin siderophore-deficient group III B. bronchiseptica mutants
BRM3 and BRM5. The upper map depicts the 8.5-kb XhoI DNA fragment
shared by four distinct group III-complementing B. pertussis cosmids. The rela-
tive positions of opposing mini-Tn5/lacZ1 transposon insertions defining BRM3
and BRM5 are indicated by the triangles (3, BRM3 insertion, and 5, BRM5
insertion). The lower map shows the limits of the minimal complementing 2.8-kb
B. pertussis DNA fragment identified. The D symbol indicates that one terminus
of the fragment was generated by exonuclease III treatment. The relative posi-
tion of an open reading frame resembling pyridoxal phosphate-dependent amino
acid decarboxylases is indicated by the arrow labeled odc.
FIG. 2. Multiple primary amino acid sequence alignment of translated B.
pertussis DNA sequences with amino acid decarboxylases identified in BLAST
database searches. The partial decarboxylase sequences shown represent the
highest-scoring 63-amino-acid segment of similarity with a deduced B. pertussis
polypeptide sequence. Residue positions of translated decarboxylase amino acid
sequences are numbered as they appear in the GenBank database submissions
(GenBank accession numbers: B. pertussis Odc, U34895; H. alvei LDC, P05033;
E. coli CadA, P23892; E. coli Adi, P28629; E. coli SpeC, P21169; E. coli SpeF,
P24169).
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ucts of lysine decarboxylase, arginine decarboxylase, or Odc
activities, respectively. Iron-regulated alcaligin production by
BRM3 was restored to wild-type levels by medium supplemen-
tation with putrescine (1,4-diaminobutane) and only partially
restored by supplementation with agmatine (1-amino-4-gua-
nidobutane) (Fig. 4). Cadaverine supplementation had no ef-
fect on siderophore production by BRM3, nor did supplemen-
tation with ornithine, arginine, or spermidine in other
experiments. All supplements had no effect on alcaligin pro-
duction by wild-type B013N, except putrescine, which resulted
in a slight enhancement of siderophore production.
In E. coli, putrescine can be produced by two alternative
biochemical pathways (34): the first and most efficient route is
direct decarboxylation of ornithine, and the second is a two-
step process involving decarboxylation of arginine to form ag-
matine, followed by the conversion of agmatine to putrescine
by the action of agmatine ureohydrolase (Fig. 5). Full restora-
tion of siderophore production to BRM3 by putrescine and
partial restoration by agmatine were consistent with the pre-
dicted involvement of an amino acid decarboxylase activity,
possibly either an Odc or an arginine decarboxylase, in the
production of putrescine, the proposed precursor of the Bor-
detella siderophore alcaligin on the basis of structural analysis.
Inhibition of Bordetella alcaligin production by an inhibitor
of Odc. Supplementation of iron-depleted SS culture medium
with the Odc inhibitor DAB resulted in strong reduction in
siderophore levels achieved by wild-type B. bronchiseptica
B013N (Fig. 6). Alcaligin production was highly sensitive to
DAB inhibition; the lowest inhibitor concentration tested,
0.001 mM, decreased siderophore production by approxi-
mately 20%. At 0.080 mM DAB, inhibition was near maximal
at approximately 50% inhibition of siderophore production
compared with untreated cultures. DAB concentrations used
FIG. 4. Alcaligin siderophore production by B. bronchiseptica in culture me-
dium supplemented with amino acid decarboxylase products. Mean relative CAS
siderophore activities (12 A/Aref, n5 3) of wild-type parent strain B013N (open
bars) and group III mutant BRM3 (hatched bars) after 24 h of growth in
unsupplemented medium (None) or in culture medium supplemented with 50 mg
of cadaverine, agmatine, or putrescine per ml are shown.
FIG. 3. Expression of an 86-kDa polypeptide encoded by the B. pertussis odc
region with a bacteriophage T7 RNA polymerase-promoter expression system in
E. coli. Samples: pGEM4Z, K38 (pGP1-2, pGEM4Z) vector control; pT7/odc,
K38 (pGP1-2, pT7/odc). U, uninduced cultures; I, induced for expression of T7
promoter-directed genes by temperature shift; I1R, induced by temperature
shift in the presence of rifampin. Positions of marker proteins are given along
with their apparent molecular masses in kilodaltons. Positions of radiolabeled
products corresponding to the vector-encoded b-lactamase product(s) and the
B. pertussis DNA-encoded product Odc are indicated.
FIG. 5. Alternative pathways for biosynthesis of putrescine in E. coli involve
SpeA (arginine decarboxylase) or SpeC (Odc).
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were not growth inhibitory over the culture period examined,
and control assays established that DAB did not interfere with
the CAS siderophore assay.
Restoration of siderophore production to mutant BRM3 by
the speC constitutive Odc-encoding gene of E. coli. Concordant
with the decarboxylase product feeding results, the sidero-
phore biosynthesis defect of BRM3 was functionally comple-
mented in trans by plasmid pRK/3.2P, encoding the heterolo-
gous Odc activity SpeC of E. coli (8) (Table 1). Alcaligin levels
produced by BRM3 (pRK/3.2P) approximated those of wild-
type B. bronchiseptica B013N and BRM3 carrying the group
III-complementing B. pertussis plasmid pRK/143.1.
Restoration of Odc activity to BRM3 by plasmids comple-
menting its siderophore biosynthesis defect. In Odc assays,
group III siderophore-deficient mutant BRM3 was found to
lack significant levels of Odc activity compared with the wild-
type parent strain B013N (Table 1). Counts determined were
in close agreement with integrated values resulting from com-
puter analysis of digitized autoradiographic images. Activities
for mutant BRM3 and BRM3 carrying the plasmid vector
pRK415 were essentially the same as nonenzymatic back-
ground activity of boiled B013N suspensions. Levels of Odc
activity comparable to those expressed by wild-type B013N
were restored to BRM3 by the B. pertussis plasmid, pRK/143.1,
that complemented its siderophore biosynthesis defect, indi-
cating that the amino acid decarboxylase activity required for
alcaligin biosynthesis is an Odc. Bordetella Odc enzymatic ac-
tivities appeared to be largely independent of iron concentra-
tion in the culture medium, suggesting that the previously
reported Fur-mediated iron regulation of Bordetella sid-
erophore biosynthesis (9) is exerted over other alcaligin bio-
synthetic activities.
Construction and analysis of a group III-analogous mutant
of B. pertussis. Siderophore-deficient B. pertussis mutant P12
was constructed by allelic exchange by using a deletion-re-
placement pRTP1 derivative to delete approximately 1 kb of
N-terminal coding sequences of the B. pertussis Odc-encoding
gene required for alcaligin biosynthesis. Deletion of the 3.8-kb
B. pertussis genomic DNA fragment depicted in Fig. 1 and
replacement by the 2.1-kb Tn5-derived kanamycin resistance
cassette were confirmed by Southern hybridization analysis of
genomic DNA isolated from a dozen independent kanamycin-
resistant derivatives. As with B. bronchiseptica mutant BRM3,
B. pertussis P12 was incapable of alcaligin siderophore produc-
tion unless supplied with the wild-type DNA sequences in trans
or unless the iron-depleted growth medium was supplemented
with putrescine (Fig. 7). These data establish that the Odc, for
which we propose the genetic designation odc, is required for
biosynthesis of the siderophore alcaligin (Fig. 8) in B. pertussis
as well as in B. bronchiseptica.
DISCUSSION
We report the identification of the odc gene encoding an
enzymatic activity essential for alcaligin siderophore biosynthe-
sis in Bordetella spp. This Odc supplies the alcaligin precursor
1,4-diaminobutane, commonly known as putrescine. The in-
volvement of an amino acid decarboxylase activity in the bio-
synthesis of alcaligin was predicted on the basis of database
searches of translated DNA sequences corresponding to the
genomic region interrupted by transposon insertions defining
previously reported B. bronchiseptica alcaligin-deficient mu-
FIG. 6. Inhibition of alcaligin siderophore production in B. bronchiseptica by
an inhibitor of Odc. Mean relative CAS siderophore activities (1 2 A/Aref, n 5
3) of 18-h B013N cultures are plotted as a function of concentration (millimo-
lars) of the Odc inhibitor DAB added to the culture medium.
TABLE 1. Alcaligin siderophore production and Odc
activities of B. bronchiseptica
Strain
Alcaligin
siderophore
productiona
Odc activityb
1 Ironc 2 Irond 1 Iron 2 Iron
B013N (wt) 0.019 0.574 362 407
BRM3 0.014 0.052 46 34
BRM3 (pRK415 vector) 0.012 0.085 26 7
BRM3 (pRK143.1) odc1 0.013 0.570 338 363
BRM3 (pRK3.2P) speC1 0.013 0.543 NDe ND
aMean relative CAS siderophore activities (1 2 A/Aref, n 5 3) of 24-h SS
cultures.
bMean disintegrations per minute (14CO2, n 5 3) evolved over a 2-h reaction
period by 2 3 108 bacterial cells.
c 1 Iron, iron-replete culture conditions.
d 2 Iron, iron-depleted culture conditions.
e ND, not determined.
FIG. 7. Alcaligin siderophore production by B. pertussis odc mutant P12
constructed by allelic exchange. Mean relative CAS siderophore activities (1 2
A/Aref, n 5 3) of 24-h cultures of odc mutant P12 carrying the designated
plasmids or supplemented with putrescine are shown versus that of the wild-type
parent strain UT25. wt, wild type.
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tants BRM3 and BRM5. Evidence supporting the involvement
of an Odc activity was gained in mutant feeding experiments in
which culture medium supplementation with decarboxylated
ornithine (putrescine) fully restored alcaligin biosynthetic ca-
pacity to BRM3. Accordingly, the alcaligin biosynthesis defect
of BRM3 was functionally complemented by expression of a
heterologous Odc activity, SpeC of E. coli. Ultimately, BRM3
was shown to be defective in Odc activity compared with its
wild-type parent B013N in crude enzyme assays, and wild-type
Odc activity levels were restored to BRM3 by plasmids shown
to complement its alcaligin biosynthesis defect. An Odc mutant
of B. pertussis constructed by allelic exchange was likewise
unable to produce alcaligin. The identification of putrescine as
a precursor of alcaligin in Bordetella spp. is in agreement with
earlier predictions based on the known structure of the sid-
erophore.
The siderophore alcaligin was first purified from the taxo-
nomically related species A. denitrificans subsp. xylosoxydans,
isolated from freshwater lake sediment (35, 36). Structural
analysis found alcaligin to be a symmetric 20-membered ring,
1,8(S),11,18(S)-tetrahydroxy-1,6,11,16-tetraazacycloeicosane-
2,5,12,15-tetrone. The dihydroxamate molecule can thus be
considered a cyclic dimer of two structural units consisting of
1-amino-4-(N-hydroxylamino)-2(S)-butanol and succinic acid.
Consistent with this twofold symmetric structure, high-resolu-
tion proton and carbon nuclear magnetic resonance spectros-
copy recently determined that the molecule displays a twofold
symmetric conformation in aqueous solution, although evi-
dence suggests that multiple C2-symmetric conformations of
alcaligin coexist in aqueous and methanolic solution (10). Al-
caligin shares structural features with the ferrioxamine family
of siderophores (30), which are produced by actinomycetes as
well as certain enterobacterial species such as H. alvei (55). All
ferrioxamines incorporate hydroxylated polyamines and suc-
cinic acid in their molecular structures. It is possible that LDC
of H. alvei identified in database searches as a homolog of
Bordetella Odc may be required for production of the cadav-
erine portion of Hafnia ferrioxamines. Alcaligin most resem-
bles the only other known cyclic dihydroxamate siderophore,
bisucaberin, produced by the marine bacterium Alteromonas
haloplanktis (23, 48). However, bisucaberin includes two resi-
dues of N-hydroxycadaverine instead of the hydroxyl-substi-
tuted N-hydroxyputrescine residues of alcaligin.
Certain catechol-type siderophores, such as agrobactin (37),
vibriobactin (20), and parabactin (47) also contain polyamines,
and in Paracococcus denitrificans, along with parabactin sidero-
phore production, spermine production increases by an order
of magnitude in response to iron starvation, although spermi-
dine and not spermine donates its triamine backbone to the
siderophore (5).
Remarkable parallels exist between the Bordetella odc gene
and the recently described hdc gene of Vibrio anguillarum re-
quired for biosynthesis of the siderophore anguibactin (49),
a trait necessary for virulence. As with Bordetella odc, the V.
anguillarum hdc gene was identified after transposon mutagen-
esis on the basis of a siderophore-deficient phenotype. Nucle-
otide sequence analysis of the mutated region of plasmid pJM1
identified deduced amino acid sequence similarities with known
histidine decarboxylases. Anguibactin siderophore production
by V. anguillarum hdc mutants was restored by culture medium
supplementation with histamine, the product of histidine de-
carboxylation, confirming the predicted role of histamine as an
essential precursor of that siderophore. Further, neither odc
nor hdc is repressible by iron, although alcaligin and anguibac-
tin siderophore production have been shown to be negatively
regulated by the action of a Fur repressor (9, 50), indicating
that iron concentration controls other siderophore biosynthe-
tic activities.
On the basis of the elucidation of the alcaligin biosynthesis
role of odc in Bordetella spp. and the known structure of al-
caligin, we hypothesize the subsequent action of an oxygenase
catalyzing the hydroxylation of putrescine. This putative Bor-
detella oxygenase would supply an activity analogous to the
IucD L-lysine N6-hydroxylase of E. coli (22), involved in the
biosynthesis of the hydroxamate siderophore aerobactin, and
to the L-ornithine N5-oxygenases PvdA of Pseudomonas aerugi-
nosa (51) and Sid1 of Ustilago maydis (31), required for pyover-
din and ferrichrome siderophore biosynthesis, respectively.
Preliminary nucleotide sequencing of the B. pertussis DNA
corresponding to the B. bronchiseptica genomic region inter-
rupted by transposons defining the group I alcaligin sid-
erophore-deficient mutants BRM1 and BRM9 (GenBank ac-
cession number U34894) identified an open reading frame
predicted to encode such a Bordetella homolog of the IucD,
PvdA, and Sid1 oxygenases (24). Confirmation of the role of
this putative Bordetella oxygenase in the biosynthesis of alcali-
gin awaits further biochemical analysis.
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